Skip to content
★ Sign in to follow
BJ
Total declarations
340
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (160 ops.)
€17.9M

Latest filing published 14 Apr 2020 for Iradimed CORP, €5,418.

Filing timeline

BuySale
Brent Johnson

First 200 filings with a declared amount

Insider track record

Disclosed buys
0
Disclosed sells
160
Signal history

Brent Johnson: trading record in brief

Brent Johnson discloses dealings in Iradimed Corp to SEC (Form 4). Between 2 December 2015 and 10 April 2020, the trades on record add up to 340 filings.

On the market, this insider has only sold: 160 sales, €17.9M in total. Besides market trades, the filings include 149 share grants and 31 option exercises. 2020 to date brings no purchases and 28 sales.

Most recently, on 14 April 2020, the filings show an option exercise worth €5,418 in Iradimed Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Brent Johnson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations330 total
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    5,920 USD11SEC
    4,000 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000499:0
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    80,440 USD11SEC
    4,000 shares@ US$20.110.6% of flowCommon StockSEC:0000898432-20-000499:1
  • ◆
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    26,827 USD11SEC
    1,342 shares@ US$19.990.2% of flowCommon StockSEC:0000898432-20-000499:3
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    0SEC
    2,065 sharesCommon StockSEC:0000898432-20-000499:2
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    5,920 USD11SEC
    4,000 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000487:0
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    80,360 USD11SEC
    4,000 shares@ US$20.090.7% of flowCommon StockSEC:0000898432-20-000487:1
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    5,920 USD11SEC
    4,000 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000487:2
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    80,120 USD11SEC
    4,000 shares@ US$20.030.6% of flowCommon StockSEC:0000898432-20-000487:3
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    5,920 USD11SEC
    4,000 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000487:4
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    80,040 USD11SEC
    4,000 shares@ US$20.010.6% of flowCommon StockSEC:0000898432-20-000487:5
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    5,920 USD11SEC
    4,000 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000466:0
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    80,000 USD11SEC
    4,000 shares@ US$20.000.6% of flowCommon StockSEC:0000898432-20-000466:1
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    5,920 USD11SEC
    4,000 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000466:2
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    80,640 USD11SEC
    4,000 shares@ US$20.160.6% of flowCommon StockSEC:0000898432-20-000466:3
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    1,792 USD11SEC
    1,211 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000466:4
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    24,426 USD11SEC
    1,211 shares@ US$20.170.2% of flowCommon StockSEC:0000898432-20-000466:5
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    728 USD11SEC
    492 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000435:0
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    20,240 USD11SEC
    1,002 shares@ US$20.200.2% of flowCommon StockSEC:0000898432-20-000435:3
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    148 USD11SEC
    100 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000435:4
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    2,003 USD11SEC
    100 shares@ US$20.030.0% of flowCommon StockSEC:0000898432-20-000435:5
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    1,483 USD11SEC
    1,002 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000435:2
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    9,845 USD11SEC
    492 shares@ US$20.010.1% of flowCommon StockSEC:0000898432-20-000435:1
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    3,217 USD11SEC
    3,459 shares@ US$0.930.0% of flowCommon StockSEC:0000898432-20-000253:0
  • ▼
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    80,318 USD29SEC
    3,459 shares@ US$23.220.6% of flowCommon StockSEC:0000898432-20-000253:1
  • ◇
    Exec. VP of WW Sales and MktgExecutivesIradimed Corp
    3,761 USD11SEC
    2,541 shares@ US$1.480.0% of flowCommon StockSEC:0000898432-20-000253:2

25 of 330 declarations